Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Combining stem cells with ATP significantly boosts hair regrowth in mice with hair loss.

Targeting specific metabolic and ionic pathways may improve alopecia areata treatment.

IVIg treatment improved symptoms but caused permanent dark hair loss.

Thyroid autoimmunity may be involved in some female hair loss, suggesting the need to test for thyroid antibodies in these patients.

Botulinum toxin type A injections may help treat hidradenitis suppurativa.

Testosterone increases acidification in the vas deferens by up-regulating V-ATPase.

Advanced therapy medicinal products show promise for vitiligo treatment with fewer side effects, but affordability is a challenge.

Changes in certain RNA and protein levels may contribute to alopecia areata and could be treatment targets.

A woman's hair loss improved after removing a tumor in her thymus gland, suggesting hair loss can be linked to such tumors even without a specific muscle weakness condition.

The combination of Typhonium flagelliforme extract and natural interferons effectively reduces tumor growth in mice.

Enhancing Tregs can protect against alopecia areata.

Type 1 diabetes often occurs with other autoimmune diseases, and personalized treatment based on genetics can improve outcomes.

IL-15 and TNF-α levels are higher in alopecia areata patients, especially in alopecia totalis.

A mutation in the IKZF1 gene causes immune system overactivity, linked to autoimmune diseases like lupus.

Minoxidil and botulinum toxin are equally effective for treating female hair loss.

Docetaxel is safe and works well for older people with cancer, with manageable side effects.

Targeting the Warburg effect in anaplastic thyroid carcinoma may reduce tumor growth and improve treatment.

Certain small molecules can promote hair growth by activating a cellular cleanup process called autophagy.

Teicoplanin may help treat hair loss by reducing androgen receptors and boosting hair cell growth.

A new hair loss treatment uses tiny needles to deliver a drug-loaded lipid carrier, promoting hair growth more effectively than current treatments.

Tofacitinib may help treat severe childhood alopecia areata, but risks require careful consideration.

Intradermotherapy is a safe and effective short-term treatment for hair loss.

Alternative treatments are needed when Tofacitinib alone fails for alopecia areata.

Both treatments improved alopecia areata, but methotrexate caused more skin darkening, while triamcinolone caused skin lightening and thinning.

Targeting specific metabolic and ionic pathways may improve alopecia areata treatment.

People with Alopecia areata have higher levels of certain T regulatory cells in their blood.

Alopecia areata may be caused by antibodies targeting specific hair follicle proteins, hindering hair growth.

Tofacitinib helps regrow hair in severe alopecia patients, but more research is needed.

Topical tacrolimus reduces certain growth factors in hair follicles.